Ozempic-Type Drugs Show Promise in Treating Addiction
New research suggests that GLP-1 agonist drugs, such as Ozempic and Wegovy, may help treat addiction by influencing the brain's reward circuitry. While originally designed for diabetes and weight loss, these medications show potential in reducing cravings for alcohol, nicotine, and other substances.
Why it matters
Repurposing existing weight-loss drugs for addiction treatment could provide a breakthrough in addressing substance abuse disorders.
For many people, the thought of a tasty burger or a cold pint of beer conjures up a vivid mental image and drives behaviour.
The article presents scientific findings and potential medical applications objectively without taking a stance on policy or ethics.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in